Immune checkpoint inhibitor-induced colitis is mediated by polyfunctional lymphocytes and is dependent on the IL23/IFNg axis

被引：0
|
作者：
Lo, J. [1 ]
Cozzetto, D. [1 ]
Madgwick, M. [2 ,3 ]
Sieh, J. Y. X. S. [4 ]
Olbei, M. [2 ]
Alexander, J. L. [1 ]
Blanco, J. Miguens [1 ]
Kudo, H. [1 ]
Ibraheim, H. [1 ]
Liu, Z. [1 ]
Seoane, R. Castro [1 ]
Goldin, R. [1 ]
Marchesi, J. [1 ]
Korcsmaros, T. [1 ,2 ]
Lord, G. [5 ]
Powell, N. [1 ]
机构：
[1] Imperial Coll London, Dept Metab Digest & Reprod, London, England
[2] Earlham Inst, Organisms & Ecosyst, Norwich, Norfolk, England
[3] Quadram Inst Biosci, Gut Microbes & Hlth Programme, Norwich, Norfolk, England
[4] Kings Coll London, Sch Immunol & Microbial Sci, London, England
[5] Univ Manchester, Fac Biol, Manchester, Lancs, England
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P001
引用
收藏
页码：I135 / I135
页数：1
相关论文
共 50 条
  • [31] Topical beclometasone dipropionate in the management of immune checkpoint inhibitor-induced microscopic colitis
    Ibraheim, Hajir
    Green, Michael
    Papa, Sophie
    Powell, Nick
    BMJ CASE REPORTS, 2019, 12 (04)
  • [32] Immune Checkpoint Inhibitor-Induced Colitis: How Long Does the Threat Last?
    Sarmiento, Paola Michelle Calle
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (06)
  • [33] A case of refractory immune checkpoint inhibitor-induced colitis with Clostridioides difficile infection
    Okura, Yukito
    Kobayashi, Katsumasa
    Yamada, Yurina
    Furuya, Makoto
    Kitano, Naoki
    Oshina, Eri
    Matsuoka, Mana
    Nozaka, Takahito
    Tashiro, Yoshihiro
    Sato, Ayako
    Yauchi, Masato
    Matsumoto, Taichi
    Furumoto, Yohei
    Asano, Toru
    Azuma, Seishin
    DEN OPEN, 2023, 3 (01):
  • [34] Refractory Immune Checkpoint Inhibitor-Induced Colitis Improved by Tacrolimus: A Case Report
    Kunogi, Yasuhito
    Tominaga, Keiichi
    Abe, Keiichiro
    Kanazawa, Mimari
    Tanaka, Takanao
    Watanabe, Shoko
    Kondo, Masayuki
    Kanamori, Akira
    Iijima, Makoto
    Goda, Kenichi
    Nozawa, Yumi
    Ishida, Kazuyuki
    Irisawa, Atsushi
    HEALTHCARE, 2021, 9 (04)
  • [35] Importance of endoscopic and histological evaluation in the management of immune checkpoint inhibitor-induced colitis
    Abu-Sbeih, Hamzah
    Ali, Faisal S.
    Luo, Wenyi
    Qiao, Wei
    Raju, Gottumukkala S.
    Wang, Yinghong
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [36] Vedolizumab in the treatment of immune checkpoint inhibitor-induced colitis: Two case reports
    Zhang, Zhe
    Zheng, Chang-Qing
    FRONTIERS IN ONCOLOGY, 2022, 12 : 10550 - 10558
  • [37] Complete Recovery of Immune Checkpoint Inhibitor-induced Colitis by Diverting Loop Ileostomy
    Horisberger, Karoline
    Portenkirchner, Carmen
    Rickenbacher, Andreas
    Biedermann, Luc
    Gubler, Christoph
    Turina, Matthias
    JOURNAL OF IMMUNOTHERAPY, 2020, 43 (04) : 145 - 148
  • [38] The Importance of Endoscopic and Histological Evaluation in the Management of Immune Checkpoint Inhibitor-Induced Colitis
    Abu-Sbeih, Hamzah
    Ali, Faisal S.
    Luo, Wenyi
    Raju, Gottumukkala
    Wang, Yinghong
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S112 - S113
  • [39] Who is at risk for immune checkpoint inhibitor-induced colitis among Korean patients?
    Kim, Ji Hyun
    Park, Sung Chul
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2025, 40 (01): : 3 - 4
  • [40] Vitamin D intake is associated with decreased risk of immune checkpoint inhibitor-induced colitis
    Grover, Shilpa
    Dougan, Michael
    Tyan, Kevin
    Giobbie-Hurder, Anita
    Blum, Steven M.
    Ishizuka, Jeffrey
    Qazi, Taha
    Elias, Rawad
    Vora, Kruti B.
    Ruan, Alex B.
    Martin-Doyle, William
    Manos, Michael
    Eastman, Lauren
    Davis, Meredith
    Gargano, Maria
    Haq, Rizwan
    Buchbinder, Elizabeth I.
    Sullivan, Ryan J.
    Ott, Patrick A.
    Hodi, F. Stephen
    Rahma, Osama E.
    CANCER, 2020, 126 (16) : 3758 - 3767
12345